FDA Approved Drugs by Medical Condition

Search by medical condition for drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Select the letter below that corresponds to the first letter of the medical condition you are searching for and all approved drugs classified under that category will be listed below.

Epilepsy

Briviact (brivaracetam) (by UCB), Approved February 2016
For the treatment of partial onset seizures related to epilepsy

Carnexiv (carbamazepine) (by Lundbeck), Approved October 2016
replacement therapy when oral administration is not feasible, in adults with seizures

Depakote (divalproex sodium) (by Abbott Laboratories), Approved June 1996
Treatment for epilepsy

Fycompa (perampanel) (by Eisai), Approved October 2012
For the treatment of partial-onset seizures with or without secondarily generalized seizures; tonic-clonic seizures

Keppra (by UCB), Approved November 1999
Levetiracetam tablets for adjunctive treatment of partial onset seizures in adults with epilepsy

Lamictal Chewable Dispersible Tablets (by GlaxoSmithKline), Approved August 1998
Treatment for Epilepsy

Nayzilam (midazolam) (by UCB), Approved May 2019
For the treatment of intermittent, stereotypic episodes of frequent seizure activity

Neurontin (gabapentin) oral solution (by Parke-Davis), Approved March 2000
Treatment of partial seizures in adults with epilepsy

Oxtellar XR (oxcarbazepine extended release) (by Supernus Pharmaceuticals), Approved October 2012
For the adjunctive therapy of partial seizures in adults and in children 6 years to 17 years of age

Tegretol (carbamazepine) (by Ciba Pharmaceuticals), Approved March 1996
Treatment for young children with epilepsy

Tegretol XR (carbamazepine) (by Ciba-Geigy), Approved May 1996
Anti-epileptic treatment

Trileptal (oxcarbazepine) Tablets (by Novartis), Approved January 2000
Approved for use as adjunctive therapy in the treatment of partial seizures in children (monotherapy for adults)

Vimpat (lacosamide) (by Schwarz Pharma), Approved October 2008
For the treatment of partial-onset seizures in adults with epilepsy

Zonegran (zonisamide) Capsules (by Dainippon Pharmaceutical), Approved March 2000
Adjunctive therapy for treatment of partial seizures in adults with epilepsy

Epilepsy (Pediatric)

Briviact (brivaracetam) (by UCB), Approved February 2016
For the treatment of partial onset seizures related to epilepsy

Fycompa (perampanel) (by Eisai), Approved October 2012
For the treatment of partial-onset seizures with or without secondarily generalized seizures; tonic-clonic seizures

Nayzilam (midazolam) (by UCB), Approved May 2019
For the treatment of intermittent, stereotypic episodes of frequent seizure activity

Oxtellar XR (oxcarbazepine extended release) (by Supernus Pharmaceuticals), Approved October 2012
For the adjunctive therapy of partial seizures in adults and in children 6 years to 17 years of age